Incidence of Second Malignancies for Prostate Cancer
Open Access
- 21 July 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (7), e102596
- https://doi.org/10.1371/journal.pone.0102596
Abstract
There is a need to assess risk of second primary cancers in prostate cancer (PCa) patients, especially since PCa treatment may be associated with increased risk of second primary tumours. We calculated standardized incidence ratios (SIRs) for second primary tumours comparing men diagnosed with PCa between 1980 and 2010 in the Canton of Zurich, Switzerland (n = 20,559), and the general male population in the Canton. A total of 1,718 men developed a second primary tumour after PCa diagnosis, with lung and colon cancer being the most common (15 and 13% respectively). The SIR for overall second primary cancer was 1.11 (95%CI: 1.06–1.17). Site-specific SIRs varied from 1.19 (1.05–1.34) to 2.89 (2.62–4.77) for lung and thyroid cancer, respectively. When stratified by treatment, the highest SIR was observed for thyroid cancer (3.57 (1.30–7.76)) when undergoing surgery, whereas liver cancer was common when treated with radiotherapy (3.21 (1.54–5.90)) and kidney bladder was most prevalent for those on hormonal treatment (3.15 (1.93–4.87)). Stratification by time since PCa diagnosis showed a lower risk of cancer for men with PCa compared to the general population for the first four years, but then a steep increase in risk was observed. In the Canton of Zurich, there was an increased risk of second primary cancers among men with PCa compared to the general population. Increased diagnostic activity after PCa diagnosis may partly explain increased risks within the first years of diagnosis, but time-stratified analyses indicated that increased risks remained and even increased over time.Keywords
This publication has 20 references indexed in Scilit:
- Second primary cancers after radiation for prostate cancer: a review of data from planning studiesRadiation Oncology, 2013
- Cancer survivors in Switzerland: a rapidly growing population to care forBMC Cancer, 2013
- Androgen Deprivation Therapy for Treatment of Localized Prostate Cancer and Risk of Second Primary MalignanciesCancer Epidemiology, Biomarkers & Prevention, 2013
- Causes of Death After Radical Prostatectomy at a Large Tertiary CenterJournal of Urology, 2012
- Prostate Brachytherapy and Second Primary Cancer Risk: A Competitive Risk AnalysisJournal of Clinical Oncology, 2011
- Radiation Therapy for Prostate Cancer Increases the Risk of Subsequent Rectal CancerAnnals of Surgery, 2011
- Increased risk of colon cancer after external radiation therapy for prostate cancerInternational Journal of Cancer, 2008
- Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestineEuropean Journal of Cancer, 2008
- Cancer incidence after localized therapy for prostate cancerCancer, 2006
- Serum Levels of Insulin Growth Factor (IGF-I) and IGF-Binding Protein Predict Risk of Second Primary Tumors in Patients with Head and Neck CancerClinical Cancer Research, 2004